New Data Surrounding Pediatric Pneumococcal Disease Shows Promise

Pharmacy Times spoke with Luwy Musey, executive director in biologics and vaccines clinical research at Merck, about the results from two phase 3 pediatric studies surrounding pneumococcal disease that was presented at the IDWeek 2021 conference.

Musey discussed the highlights of the new data and how these 2 studies are different than previous studies in this topic area.